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Abstract 
Objective: This study summarizes current literature on the association between high deductible 
health plans (HDHPs) and outcomes for patients with diabetes, as well as elucidates factors that 
may be influencing the association between the two variables.  
Methods: A rapid realist review was conducted to synthesize empirical studies on the 
implementation of HDHPs among populations with diabetes. Study outcomes varied but 
included emergency department visits, outpatient visits, and medication adherence.  
Results: Sixteen articles were selected for inclusion in the review. Eleven found an association 
between HDHP enrollment and adverse health outcomes. Across studies, three factors influenced 
the effects of HDHPs on diabetes patients: income, health literacy, and intentionality of plan 
choice. Policy solutions to address each of these factors were distilled from the suggestions in 
each study.  
Conclusions: These findings elucidate certain factors that should be at the forefront of any 
discussion on reforming HDHP structure in the United States. This review will inform the scope 
of future work conducted by the Center for the Business of Health at UNC on the effects of 
HDHPs. Future research is needed with more specific outcomes measures to confirm that 
adverse health outcomes are being experienced by vulnerable populations.    
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Introduction 
Health care spending in the United States has risen faster than overall gross domestic 
product growth over the past 25 years. The Center for Medicare and Medicaid Services projects 
that healthcare spending will continue to rise at an average rate of 5.5% annually from 2017 to 
2026. By 2026, healthcare spending is projected to comprise 19.7% of the US economy, or an 
estimated $5.7 trillion (Abutaleb, 2018). As health costs have continued to increase, insurance 
costs have also increased for both the individual and group markets.  
High deductible health plans (HDHP) have emerged as a mechanism to mitigate 
increasing health care cost growth by reducing utilization. Patients using HDHPs pay a reduced 
monthly premium, but are responsible for paying a higher portion of their care before receiving 
insurance benefits. The Internal Revenue Service specifically defines high deductibles as $1,350 
for an individual or $2,700 for a family, with total yearly out-of-pocket expenses capped at 
$6,650 for an individual or $13,300 for a family (US Centers for Medicare & Medicaid 
Services). Proponents of HDHPs have argued that such plans incentivize patients to select 
cheaper treatment options, as they themselves have to pay a higher upfront price. Fundamental 
microeconomic theory suggests that higher prices will inevitably lead to lower levels of demand 
(Whelan & Msefer, 1996). HDHPs today are often combined with a savings option, which 
allows people to set aside pre-tax dollars to be used for out-of-pocket health care expenses. 
These savings options include tax-free individual health savings accounts (HSAs) and employer 
sponsored HRAs. Such HDHP/SO combined plans are known as consumer directed health plans 
(CDHPs).  
As CDHPs have become more prevalent, they have remained controversial in the 
political sphere. Some employers have begun to question their value; large companies like 
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JPMorgan Chase & Co. and CVS Health Corp. are exploring strategies to reduce deductibles for 
employees (Tozzi & Tracer, 2018). High deductible health plans may have lower premiums than 
traditional plans, but also may result in patients facing astronomical bills after a medical episode. 
According to the Federal Reserve Board, 40% of Americans would not be able to cover a $400 
emergency expense without borrowing or selling possessions (2018). At the same time, 39% of 
large employers today offer only consumer directed health plans (National Business Group on 
Health, 2018). These persistent issues highlight the importance of determining whether HDHPs 
are effective in not only reducing costs, but also improving the health of the overall population.  
The Center for the Business of Health Project 
While the literature indicates high deductible health plans (HDHPs) are effective in 
reducing healthcare spending and utilization, there is a need for understanding the impact of 
HDHPs on health care status and outcomes to inform future policy. The Center for the Business 
of Health at the University of North Carolina’s Kenan-Flagler Business School is commencing a 
project (hereafter referred to as the ‘CBOH project’) to develop policy solutions aimed at 
optimizing the utilization of high deductible health plans.  
As a preceding work to the CBOH project, the primary objectives for this synthesis were 
the following: 
1. Identify any studies that have been conducted previously analyzing a relationship 
between health plan type and diabetes outcomes.  
2. Understand the social, political, and economic mechanisms that contribute to the 
observed effects in diabetes outcomes.  
3. Inform the scope of an expert roundtable discussion on enhancing HDHP design.   
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To accomplish the above objectives, we conducted a rapid realist review, guided by the 
following research questions:  
1. What evidence exists regarding the outcomes experienced by patients with diabetes 
who are enrolled in high deductible health plans in the United States? 
2. What factors does the literature indicate may be influencing the observed relationship 
between high deductible health plans and outcomes for patients with diabetes?  
3. What policy solutions have been proposed to address these factors?  
Background  
 High deductible health plans came into existence as part of a movement over the past 
fifty years towards enabling patients to have greater choice in their benefits plans. Section 125, a 
1978 amendment to the Internal Revenue Code, created cafeteria plans. Cafeteria plans were 
introduced as an optional feature for employers to offer, in which employees were able to 
contribute a certain amount of their income to a pre-tax savings account to be used for healthcare 
expenses (Legal Information Institute, 2018). The 1980s and 1990s saw further expansion of 
such savings accounts, with the introduction of flexible savings accounts (FSAs), health 
reimbursement arrangements (HRAs), and medical savings accounts (MSAs) (Centers for 
Medicare & Medicaid Services, 2017). In 2003, Congress passed the Medicare Prescription Drug 
Improvement and Modernization Act, which introduced health savings accounts (HSAs). More 
than twenty states and a federal pilot program had already launched MSAs, and HSAs were 
essentially an expanded version of the existing MSAs (National Conference of State 
Legislatures, 2017). The introduction of the Affordable Care Act in the Obama Administration 
saw an increased push towards HDHPs with HSAs—the law mandated large employers to 
provide their employees with health insurance, and created health insurance exchanges for the 
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individual market (2010). As employers grappled with the higher costs of insuring all employees, 
and individuals sought out the cheapest plans on the exchanges, HDHPs were often selected as 
the option with the highest perceived cost-effectiveness.   
Both the individual and group markets have seen HDHPs increase in prevalence over the 
past decade. In 2017, US employers spent an average of $6,690 and $18,764 on premiums for 
employees in individual and family plans, respectively. However, for high-deductible health 
plans with a savings option (HDHP/SO), average premiums are significantly lower for both 
single and family coverage, at $6,024 and $17,581. As a result, 28% of covered workers are now 
enrolled in an HDHP/SO, and enrollment has increased by 9 percentage points over the past 5 
years (Kaiser Family Foundation, 2017). The individual market showed similar growth, with 
HDHP enrollment increasing from 51.9% of enrollees in 2016 to 53.5% in 2017 (Zammitti et. al, 
2017). 
Literature on HDHPs widely suggests that consumer directed health plans result in cost 
savings. Manning and Newhouse found that individuals in the highest deductible plans spend 
approximately 66% of what individuals with no cost sharing requirements spend (1987). The 
seminal study on the topic, the RAND Health Insurance Experiment, showed that increased 
consumer financial responsibility reduced both health care use and spending (Keeler et. al, 
1982). Furthermore, the RAND study found that the ultimate cost savings are a result of reduced 
utilization as opposed to consumers choosing lower cost care (Keeler, 1992). While the RAND 
study does not directly analyze the effects of HDHPs, later evidence suggests that HDHPs led to 
decreased utilization and increased spending at a slower rate than other health plans (Buntin et 
al., 2006). As HDHPs have grown prevalent, further studies have analyzed the effects of their 
adoption on a number of utilization measures, which will be further analyzed in this review. 
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The CBOH project will be specifically analyzing the effects of HDHPs on outcomes for 
diabetes patients. Diabetes is a condition that will have significant effects on our healthcare 
system going forward. In 2017, 30.3 million Americans were living with diabetes and an 
additional 84.1 million were living with prediabetes, which can lead to diabetes in less than 5 
years (Centers for Disease Control and Prevention, 2017). A project 1 in 3 Americans will have a 
diabetes diagnosis by 2050 (Boyle et. al, 2010). In 2013, while 90.1% of diagnosed diabetes 
patients had had contact with a health professional in the past 6 months, 28.8% of 18-39 year 
olds, 14.3% of 40-64 year olds, and 13.5% of those 65 and older were not taking any medication 
to control glucose levels (Villarroel et. al, 2013). Additionally, 24% of Americans visiting the 
emergency department in 2017 presented with symptoms of diabetes (Centers for Disease 
Control and Prevention, 2017) With diabetes on the horizon of being one of the United States’ 
most pressing epidemics, it is necessary to determine how trends in payment models are 
affecting clinical outcomes.   
Methods 
 We followed the RAMESES publication standards for realist review method in the 
process of developing and conducting this study (Wong et. al, 2013).   
1. Searching process 
 We searched PubMed and Embase for peer-reviewed literature in English among patient 
populations in the United States. We chose these two databases due to their prominence in the 
health policy field. Our search terms included “high deductible health plans,” “diabetes,” and 
“outcomes.” 113 articles were found in the initial search. Based on a title search, 30 articles were 
selected for full-text review.  
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2. Selection and appraisal of documents 
 One reviewer (PJ) selected the articles to be included in the review through a two-step 
process. Based on a title search, articles were excluded if they did not present an analysis of the 
relationship between high deductible health plans and outcomes experienced by patients with 
diabetes. The primary reviewer (PJ) reviewed all 30 remaining articles in their entirety. Based on 
the full-text analysis, 16 articles were selected for inclusion in the review. 
3. Data extraction 
 We extracted data from the articles and created a master data table, including study 
characteristics and outcome measures. For the studies that reported multiple outcomes, we 
included all relevant outcomes in the tables. Outcomes included emergency department visits, 
outpatient visits, medication adherence, and other measures that could be proxies for diabetes 
treatment. We did not include information regarding secondary or tertiary outcomes that were 
only superficially reported, thus disregarding mechanisms linked to weaker or coincidental 
outcomes. Covariates, or factors other than cost sharing that were proposed to have had effects 
on the measured outcomes, were also included in the second table for analysis purposes.  
4. Policy solutions review 
 After developing our data tables, we also analyzed each study for proposed policy 
solutions to address some of the shortcomings of the high deductible health plans. These 
suggestions were then grouped into overarching policy solutions proposed at the end of this 
section.    
5. Analysis and synthesis processes 
 First, we used a simple vote count table to determine the overall effect of high deductible 
health plans on diabetes outcomes in generalized terms. Based on these findings, we separated 
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the studies into groups based on the associations found. Then, we identified and highlighted 
common crosscutting themes from both the study characteristics table and the covariates table to 
determine what factors also appeared to play a role in diabetes outcomes. We distilled this 
information down to the broad factors affecting outcomes for patients with diabetes when on 
high deductible health plans. Individual examples from the studies were synthesized to distill 
aggregate effects. These factors are described in detail in the findings section of this paper.  
 We then aligned the factors we distilled to the policies proposed in each study. After 
synthesizing both components, we were able to identify overarching policy solutions to the gaps 
being experienced by the American population today.   
 At the next stage of the CBOH project, the findings of this review will be presented to an 
expert roundtable in summer 2019. Discussion from these findings will then inform the 
conceptualization of areas for improvement to optimized HDHP insurance design and utilization, 
specifically from a policy lens.  
Findings 
Association between High Deductible Health Plans and Outcomes for Patients with Diabetes 
 Even among the limited sample of 16 studies reviewed, there was considerable variation 
in a number of contextual elements, including, but not limited to, setting, demographics, 
population, outcome measures, and duration. Eleven studies found an association between high 
deductible health plans and negative outcomes for patients with diabetes. Four studies found no 
difference in patient outcomes between populations assigned to high deductible health plans and 
those assigned to low deductible health plans. One study found an association between high 
deductible health plans and positive outcomes for patients with diabetes. Notably, none of the 
studies used the traditional clinical outcome measure for diabetes, HbA1c levels. Only one study 
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looked at diabetes-specific tests, such as feet tests and diet modification, but it only studied their 
frequency, rather than results. Additionally, three of the studies looked at outcomes for patients 
with chronic diseases in aggregate, as opposed to diabetes-specific measures. Examples of 
outcomes used include emergency department visits, outpatient visits, and medication adherence. 
While this simple vote count suggests high deductible health pans are adversely affecting 
patients with diabetes, a number of factors influence whether or not this statement is true, and the 
degree to which it is true or false. Each of these studies on its own only reflects the effect of high 
deductible health plans in a specific setting and with a specific population. Together, however, 
certain factors appear to influence how high deductible health plans may be affecting clinical 
outcomes at an aggregate level.  
Factors Influencing the Effects of HDHPs on Clinical Outcomes for Patients with Diabetes 
1) Income  
 Prior literature suggests that low-income populations may be adversely affected by high 
deductible health plans to a greater degree than higher income groups. Eight studies in this 
review specifically looked at income or socioeconomic status as a covariate. While low-income 
families report significant cost pressure as a result of medical expenses regardless of plan type, 
“families in high-deductible plans were significantly more likely than those in traditional plans to 
report financial burden, including problems paying medical bills, having to set up a payment plan 
with a hospital or doctor’s office, or having trouble paying for other basic bills because of health 
care costs” (Galbraith et. al, 2011, p.7). HDHP members categorized as low-income were also 
found to have significantly increased high-severity emergency department visits, hospitalization 
days, decreased medication adherence, and decreased outpatient visits (Wharam et. al, 2018a; 
Lewey et. al, 2018; Wharam et. al, 2018c; Rabin et. al, 2017). While the RAND study and others 
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have shown that lower income individuals report higher cost savings after switching to a high 
deductible plan, these studies indicate those savings may be coming at the cost of medically 
necessary care.  
 By definition, high deductible health plans offer lower premiums, but generally result in 
higher out-of-pocket expenses when a medical event occurs. For patients suffering from chronic 
diseases like diabetes, these medical events are almost certain to occur. However, a future 
medical event may seem less pressing compared to daily needs, such as food and shelter. In such 
situations, individuals experiencing low socioeconomic status may choose to forgo non-
emergency care, such as outpatient visits or diabetes management medications. This behavior in 
turn results in an increased number of emergency events and increased high-severity emergency 
room visits. The literature analyzed in this study indicates that in the low-income subgroup, high 
deductible health plans do decrease utilization and contain costs, but may result in severe 
medical consequences.    
2) Health insurance literacy 
 Unlike the previous factor, health insurance literacy was not an analyzed covariate in the 
studies reviewed. However, in several cases, researchers found that patients were unsure of what 
exactly was covered by a new plan. Fear of increased costs that do not seem necessary in the 
moment may have restricted patients experiencing financial pressures from seeking medically 
necessary care. For example, “though preventive visits require no out-of-pocket costs, reduced 
preventive service use with HDHPs is well established and might be the result of patients being 
unaware of this benefit or their concern about findings that could lead to additional expenses” 
(Rabin et. al, 2017, p.243). One researcher noted that HDHP plan enrollees were “less educated 
and less affluent,” and may “enroll in HDHPs with less costly premiums unaware of the benefits 
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covered by their insurance plans” (Jetty et. al, 2017, p.379).  Another study noted that patients 
with HDHPs experience increased high-severity health outcomes because they may be forgoing 
primary care that is actually covered by their plans (Wharam et. al, 2018c). Several studies noted 
that education and outreach about plan benefits is necessary for patients with diabetes enrolling 
in HDHPs (Wharam et. al, 2018b; Wharam et. al, 2018c). Furthermore, studies measuring 
medication adherence as an outcome noted that enrollees appear to be aware of how their 
prescription costs are affected by HDHPs (Reiss et. al, 2011; Chernew et. al, 2009; Lewey et. al, 
2018). Because copayment changes and prescription coverage amounts are easily accessible, 
patients may be extrapolating that similar limitations apply to preventive services.  
 The Affordable Care Act mandates that HDHPs cover preventive services, including 
office visits, screening tests, immunizations, and counseling, with no out-of-pocket charges 
(Ogden et. al, 2012). According to a Kaiser Family Foundation poll, only 43% of HDHP 
enrollees were aware that this benefit was included in their plan (Hamel et. al, 2014). This lack 
of knowledge concerning the coverage of preventive services is especially dangerous among 
patients who suffer from a chronic disease like diabetes. If a lack of health insurance literacy is a 
cause of patients choosing to forgo primary care and resulting in increased high-severity 
emergency room visits among the population with diabetes, more education about these 
programs is necessary to mitigate adverse health outcomes and high emergency expenditures.  
3) Intentionality of plan selection 
 Having a choice of plan selection may also play a role in how HDHP enrollees with 
diabetes are affected by their plans. One study specifically analyzed the effects of health status 
on plan choice and found that 84.8% of patients with diabetes elected to enroll in a high premium 
versus a high-deductible health plan (Naessens et. al, 2008). This finding is to be expected, as 
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patients with diabetes are generally aware of the high costs of their condition and likely do not 
want to be paying high out-of-pocket charges.   
 However, five of the studies analyzed were conducted in settings involving an employer-
mandated switch to an HDHP. One such study noted that “when faced with increased cost 
sharing for tests or treatments for their diabetes and other health conditions, diabetes patients 
may be more inclined to reduce medication use to lower out-of-pocket health care expenses” 
(Reiss et. al, 2011, p.1394). Another study noted that those with no choice of health plans were 
more than two times as likely as those who did to experience financial burden (Galbraith et. al, 
2011). In all five of the studies considered in this group, low-income populations faced an 
increased number of adverse outcomes related to diabetes management (Reiss et. al, 2011; 
Wharam et. al, 2018a; Wharam et. al, 2018b; Wharam et. al, 2018c; Nair et. al, 2009). These 
findings indicate that those mandated to enroll in HDHPs with diabetes and limited income 
might face significant financial difficulties when paying for non-urgent medical expenses. When 
these non-urgent treatments and tests are foregone, these individuals are likely to face significant 
negative health consequences.   
Policy Solutions 
 As the 2020 presidential election approaches, how Americans pay for healthcare is a 
divisive issue in the political arena. There is consensus on both sides of the aisle that prices are 
too high, and healthcare is especially unaffordable for vulnerable populations. The 
overwhelming finding among researchers studying the topic of diabetics and high deductible 
health plans is that there is likely an association between HDHPs and negative outcomes for 
patients with diabetes, especially among vulnerable populations. The studies in this review 
proposed several policy solutions to mitigate the effects of certain factors: 
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a. Introduce income-dependent cost-sharing for necessary services (Jetty et. al, 2017; Reiss 
et. al, 2011; Galbraith et. al, 2011; Wharam et. al, 2018a; Wharam et. al, 2018b; Rabin et. 
al, 2017) 
b. Develop education tools/programs to ensure enrollees are aware of their plan benefits 
(Jetty et. al, 2017; Lee & Zapert, 2005; Wharam et. al, 2018a) 
c. Continue to provide free preventive services and introduction of free/low cost primary 
care (Jetty et. al, 2017) 
d. Discourage enrollment in HDHPs by vulnerable populations, such as those with diabetes 
(Lee & Zapert, 2005; Wharam et. al, 2018b; Wharam et. al, 2018c) 
e. Develop a standardized low-cost pharmacy benefit package for patients with essential 
medications (Reiss et. al, 2011; Rabin et. al, 2017) 
 Furthermore, several studies note the important role that providers and employers play in 
protecting vulnerable populations. As seen in this review, employers have the ability to mandate 
that their employees switch to certain plans, and should be cognizant of the effects of such 
mandates. Providers also have the responsibility to monitor patients with chronic conditions and 
advocate for patients who are unable to afford essential treatment or tests. 
 The literature clearly shows that there are a number of factors that need to be mitigated 
when considering the experiences of diabetics in high deductible health plans. Policy solutions 
have been proposed to address these factors and should be considered in further detail moving 
forward.  
Limitations  
 There are several limitations to this study. First, only one reviewer (PJ) was fully 
involved in the review process with limited input from others. While other project team members 
Joshi 16 
reviewed the results of the review and a limited number of articles, the process was not fully 
overseen by other individuals. Second, there are a limited number of studies on the association 
between high deductible health plans and outcomes for patients with diabetes. A small sample 
size may have lead to inaccurate conclusions about the associations present. Additionally, due to 
limited work being done in this area, some of the studies considered are from the same authors 
and institutions. Third, the policy exploratory search did not look beyond the studies in the 
review. It is possible that some policies being explored around the United States were missed by 
the reviewer.  
Implications 
 The findings of this paper will inform several successive pieces of work. First, other 
UNC researchers will be providing input on this review to make its findings more robust. Second, 
results will be presented to an expert roundtable in summer 2019 for input and further 
conversation on how to optimized HDHP insurance design and utilization. Third, the combined 
findings from this review and the expert roundtable will inform a white paper by the CBOH team 
in fall of 2019 on the optimization of HDHP design. Ideally, the conclusions of the larger project 
will inform the dialogue between policymakers and other stakeholders on how to develop 
insurance systems that prioritize patient needs while being economically feasible.  
 However, this project is not sufficient on its own to necessitate redesign of American 
health insurance policies. Further primary studies should be performed assessing the effects of 
high deductible health plans on observed health outcomes. As noted previously, none of the 
studies in this review analyzed the traditional diabetes health outcome, HbA1c levels. It is 
necessary for future work to analyze that relationship directly without the use of proxy outcome 
measures. Additionally, more reviews are needed across a variety of healthcare settings to assess 
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any covariates that were missed in this review. Realist review allows researchers to distill factors 
that may be overlooked in primary studies, and doing more of them will benefit the overall 
health policy community in fostering further dialogue.  
Conclusion 
This rapid realist review identified a consistent association between high deductible 
health plan enrollment and negative outcomes for patients with diabetes across 16 studies. 
Furthermore, we distilled three factors that influence how certain subpopulations respond to the 
effects of HDHPs: income, health literacy, and intentionality of plan choice. As vulnerable 
populations suffer the most adverse health outcomes due to the adoption of HDHPs, 
policymakers must address any shortcomings to protect these groups. While this review is a first 
step in elucidating how HDHP structure can be improved to best serve the American public, 
further work incorporating expert opinions and additional empirical research is necessary to 
inform policy reform.  
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Appendix A: PRISMA Flow Diagram for Study Selection 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The 
PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097 
 
The PRISMA Flow Diagram was adapted for this realist review. 
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